TY - JOUR
T1 - Pathophysiological characteristics of heart rate recovery in heart failure
AU - Wolk, Robert
AU - Somers, Virend K.
AU - Gibbons, Raymond J.
AU - Olson, Thomas P.
AU - O'Malley, Kathy A.
AU - Johnson, Bruce D.
PY - 2006/8
Y1 - 2006/8
N2 - Purpose: Heart failure (HF) is associated with blunted HR recovery after exercise. The determinants of altered HR recovery in HF are unknown. The aim of this study was to investigate clinical correlates of HR recovery in HF patients. Methods: Echocardiography, pulmonary function tests, exercise testing, and neurohormonal measurements were performed in 98 HF patients. HR recovery was calculated as the difference between heart rate at peak exercise and at l min into a recovery period. Study subjects were divided into three groups based on HR recovery tertiles: group 1 (HR recovery ≤ 6 bpm), group 2 (7 ≤ HR recovery ≤ 12), and group 3 (HR recovery ≥ 13). Results: There were significant differences between the groups in multiple parameters. Compared with group 3, patients in group 1 had greater E/A ratios (1.81 ± 0.26 vs 0.98 ± 0.12,P = 0.011), shorter deceleration time (170 ± 11 vs 223 ± 11 ms, P = 0.016), and higher plasma atrial natriuretic peptide levels (207 ± 32 vs 101 ± 12 pg·mL-1, P = 0.008), indicating higher left ventricular filling pressures and elevated left atrial pressures. Pulmonary function tests were suggestive of greater restrictive changes in the lungs. Finally, subjects in group 1 had impaired exercise capacity, as evidenced by shorter exercise duration (5.2 ± 0.2 vs 8.3 ± 0.4 min, P < 0.001), lower peak V̇O2 (14.6 ± 0.6 vs 22.2 ± 1.0 mL·kg-1·min-1, P < 0.001), higher V̇E/V̇CO2 ratios (36.4 ± 1.1 vs 31.1 ±0.9, P = 0.001), and reduced chronotropic responses to exercise (39 ± 3 vs 69 ± 4 bpm, P < 0.001). Conclusion: HR recovery may be a clinically useful index identifying HF patients with distinct echocardiographic, neurohormonal, and hemodynamic characteristics. This may have implications for our understanding of the pathophysiology of impaired HR recovery in HF as well as for the clinical evaluation of such patients.
AB - Purpose: Heart failure (HF) is associated with blunted HR recovery after exercise. The determinants of altered HR recovery in HF are unknown. The aim of this study was to investigate clinical correlates of HR recovery in HF patients. Methods: Echocardiography, pulmonary function tests, exercise testing, and neurohormonal measurements were performed in 98 HF patients. HR recovery was calculated as the difference between heart rate at peak exercise and at l min into a recovery period. Study subjects were divided into three groups based on HR recovery tertiles: group 1 (HR recovery ≤ 6 bpm), group 2 (7 ≤ HR recovery ≤ 12), and group 3 (HR recovery ≥ 13). Results: There were significant differences between the groups in multiple parameters. Compared with group 3, patients in group 1 had greater E/A ratios (1.81 ± 0.26 vs 0.98 ± 0.12,P = 0.011), shorter deceleration time (170 ± 11 vs 223 ± 11 ms, P = 0.016), and higher plasma atrial natriuretic peptide levels (207 ± 32 vs 101 ± 12 pg·mL-1, P = 0.008), indicating higher left ventricular filling pressures and elevated left atrial pressures. Pulmonary function tests were suggestive of greater restrictive changes in the lungs. Finally, subjects in group 1 had impaired exercise capacity, as evidenced by shorter exercise duration (5.2 ± 0.2 vs 8.3 ± 0.4 min, P < 0.001), lower peak V̇O2 (14.6 ± 0.6 vs 22.2 ± 1.0 mL·kg-1·min-1, P < 0.001), higher V̇E/V̇CO2 ratios (36.4 ± 1.1 vs 31.1 ±0.9, P = 0.001), and reduced chronotropic responses to exercise (39 ± 3 vs 69 ± 4 bpm, P < 0.001). Conclusion: HR recovery may be a clinically useful index identifying HF patients with distinct echocardiographic, neurohormonal, and hemodynamic characteristics. This may have implications for our understanding of the pathophysiology of impaired HR recovery in HF as well as for the clinical evaluation of such patients.
KW - Echocardiography
KW - Exercise testing
KW - Neurohormones
KW - Pulmonary function
UR - http://www.scopus.com/inward/record.url?scp=33747070238&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33747070238&partnerID=8YFLogxK
U2 - 10.1249/01.mss.0000228949.78023.a5
DO - 10.1249/01.mss.0000228949.78023.a5
M3 - Article
C2 - 16888447
AN - SCOPUS:33747070238
SN - 0195-9131
VL - 38
SP - 1367
EP - 1373
JO - Medicine and science in sports and exercise
JF - Medicine and science in sports and exercise
IS - 8
ER -